![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, August 18, 2014 10:35:09 AM
For the last 2 plus years I've stated ATRS would have difficulty signing a partnership in the EU due to lower priced competition.
Are you trying to say Medac didn't conduct user studies for their device?
Are you trying to say Beckinson Dickinson manufactures some Micky Mouse device in comparison to ATRS?
I'm just saying the need for an injector is overstated. If a person can use ATRS or Medac's injector then they could use a basic pre-filled syringe.
Before you say I'm wrong look at the steps needed to use Otrexup.
FEATURED Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM